You are here
TGA reforms: A blueprint for TGA's future: Progress report as at 31 December 2013
Background to the TGA reforms
The Therapeutic Goods Administration (TGA) was established as part of the Department of Health to safeguard and enhance the health of the Australian community through effective and timely regulation of therapeutic goods.
To ensure that we continue to fulfil our critical public health role and are able to meet industry, health professional and community expectations, several major reviews were undertaken in recent years, including:
- the review to improve transparency of the TGA
- the Working Group on Promotion of Therapeutic Products
- public consultations on the regulatory framework for advertising therapeutic goods
- the Auditor-General's report on Therapeutic Goods Regulation: Complementary Medicines
- the informal working group examining the regulation of complementary medicines and reasons for low compliance rates with particular regulations
- public consultations on the medical devices regulatory framework, and
- the Australian Government Health Technology Assessment Review.
In response to the recommendations made in the reviews TGA reforms: a blueprint for TGA's future, (the Blueprint) was released in December 2011.
On 16 July 2012 Delivering reforms - Implementation plan for TGA Reforms: A blueprint for TGA's future - was released publicly with an announcement that the TGA will report on its progress every six months, following consultation with the Australian Therapeutic Goods Advisory Council.